Cachexia: A systemic consequence of progressive, unresolved disease.

Saved in:
Bibliographic Details
Title: Cachexia: A systemic consequence of progressive, unresolved disease.
Authors: Ferrer M; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA; MRC Cancer Unit, University of Cambridge, Hutchison Research Centre, Cambridge Biomedical Campus, Cambridge CB2 0XZ, UK., Anthony TG; Department of Nutritional Sciences, Rutgers School of Environmental and Biological Sciences, The State University of New Jersey, New Brunswick, NJ 08901, USA., Ayres JS; Salk Institute for Biological Studies, La Jolla, CA 92037, USA., Biffi G; University of Cambridge, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge CB2 0RE, UK., Brown JC; Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA., Caan BJ; Kaiser Permanente Northern California Division of Research, Oakland, CA 94612, USA., Cespedes Feliciano EM; Kaiser Permanente Northern California Division of Research, Oakland, CA 94612, USA., Coll AP; Wellcome Trust-MRC Institute of Metabolic Science and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge CB2 0QQ, UK., Dunne RF; University of Rochester Medical Center, University of Rochester, Rochester, NY 14642, USA., Goncalves MD; Division of Endocrinology, Department of Medicine, Weill Cornell Medicine, New York, NY 10021, USA., Grethlein J; Ruprecht Karl University of Heidelberg, Heidelberg 69117, Germany., Heymsfield SB; Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA., Hui S; Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115, USA., Jamal-Hanjani M; Department of Medical Oncology, University College London Hospitals, London WC1E 6DD, UK; Cancer Research UK Lung Cancer Centre of Excellence and Cancer Metastasis Laboratory, University College London Cancer Institute, London WC1E 6DD, UK., Lam JM; Cancer Research UK Lung Cancer Centre of Excellence and Cancer Metastasis Laboratory, University College London Cancer Institute, London WC1E 6DD, UK., Lewis DY; The Beatson Institute for Cancer Research, Cancer Research UK, Glasgow G61 1BD, UK., McCandlish D; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA., Mustian KM; University of Rochester Medical Center, University of Rochester, Rochester, NY 14642, USA., O'Rahilly S; Wellcome Trust-MRC Institute of Metabolic Science and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge CB2 0QQ, UK., Perrimon N; Department of Genetics, Blavatnik Institute, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115, USA., White EP; Rutgers Cancer Institute of New Jersey, Department of Molecular Biology and Biochemistry, Rutgers University, The State University of New Jersey, New Brunswick, NJ 08901, USA; Ludwig Princeton Branch, Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ 08544, USA., Janowitz T; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA; Northwell Health Cancer Institute, Northwell Health, New Hyde Park, NY 11042, USA. Electronic address: janowitz@cshl.edu.
Source: Cell [Cell] 2023 Apr 27; Vol. 186 (9), pp. 1824-1845.
Publication Type: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-4172
DOI:10.1016/j.cell.2023.03.028